(1)
Hammerman, A.; Greenberg-Dotan, S.; Battat, E.; Feldhamer, I.; Bitterman, H.; Brenner, B. The ‘real-life’ Impact of Adding Bevacizumab to First-Line Therapy in Metastatic Colorectal Cancer Patients: A Large Israeli Retrospective Cohort Study. AO 2015, 54, 164-170.